Binding of [3H]-SK and F 107260 and [3H]-SB 214857 to purified integrin α(IIb)β3: Evidence for a common binding site for cyclic arginyl- glycinyl-aspartic acid peptides and nonpeptides

Journal of Pharmacology and Experimental Therapeutics

Volumn 285, Issue 1, 1998, Pages 228-235

  Wong, Angela ^a   Hwang, Shing Mei ^a   Johanson, Kyung ^a   Samanen, James ^a   Bennett, Donald ^a   Landvatter, Scott W ^a   Chen, Wenting ^a   Heys, J Richard ^a   Ali, Fadia E ^a   Ku, Thomas W ^a   Bondinell, William ^a   Nichols, Andrew J ^a   Powers, David A ^a   Stadel, Jeffrey M ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINYLGLYCYLASPARTIC ACID; CALCIUM ION; ECHISTATIN; FIBRINOGEN RECEPTOR; FIBRINOGEN RECEPTOR ANTAGONIST; INTEGRIN; LECTIN; LOTRAFIBAN; MAGNESIUM ION; MANGANESE; RADIOLIGAND; SKF 107260; TRITIUM; UNCLASSIFIED DRUG; ANTITHROMBOCYTIC AGENT; ARGINYL-GLYCYL-ASPARTIC ACID; CYCLOPEPTIDE; DIVALENT CATION; FIBRINOGEN; OLIGOPEPTIDE; PEPTIDE; SK&F 107260;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG BINDING SITE; HUMAN; HUMAN CELL; LIGAND BINDING; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION INHIBITION; BINDING COMPETITION; DOSE RESPONSE; ISOLATION AND PURIFICATION; METABOLISM; THROMBOCYTE;

BINDING, COMPETITIVE; BLOOD PLATELETS; CATIONS, DIVALENT; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBRINOGEN; HUMANS; OLIGOPEPTIDES; PEPTIDES; PEPTIDES, CYCLIC; PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX;

EID: 0032037587     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Ali FE, Bennett DB, Calvo RR, Elliott JD, Hwang JM, Ku TW, Lago MA, Nichols AJ, Romoff TT, Shah DH, Vasko JA, Wong A, Yellin TO, Yuan C-K and Samanen JM (1994) Conformationally constrained peptides and semipeptides derived from RGD as potent inhibitors of the platelet fibrinogen receptor and platelet aggregation. J Med Chem 37:769-780.
2. Alig L, Edenhofer A, Hadvary P, Hurzeler M, Knopp D, Muller M, Steiner B, Trzeciak A and Weller T (1992) Low molecular weight, non-peptide fibrinogen receptor antagonists. J Med Chem 35:4393-4407.
3. Baker PL, Bullens S, Bunting S, Burdick DJ, Chan KS, Deisher T, Eigenbrot C, Gadek TR, Gantzos R, Lipari MT, Muir CD, Napier MA, Pitti RM, Padua A, Quan C, Stanley M, Struble M, Tom JYK and Burnier JP (1992) Cyclic RGD peptide analogs as antiplatelet antithrombotics. J Med Chem 35:2040-2048.
4. Bondinell WE, Keenan RM, Miller WH, Ali FE, Allen AC, De Brosse CW, Eggleston DS, Erhard KF, Haltiwanger C, Huffman WF, Hwang SM, Jakas DR, Koster PF, Ku TW, Lee CP, Nichols AJ, Ross ST, Samanen JM, Valocik RE, Vasko JA, Venslavsky JW, Wong A and Yuan C-K (1994) Design of a potent and orally active nonpeptide platelet fibrinogen receptor (GPIIb/IIIa) antagonist. Bioorg Med Chem 2:897-908.
5. Charo IF, Nannizzi L, Phillips DR, Hsu MA and Scarborough RM (1991) Inhibition of fibrinogen binding to GPII-IIIa by a GPIIIa peptide. J Biol Chem 266:1415-1421.
6. 3 antagonists. J Med Chem 37:1-8.
7. 50) of an enzyme reaction. Biochem Pharmacol 22:3099-3108.
8. D'Souza SE, Ginsberg MH, Lam SC-T and Plow EF (1988) Chemical cross-linking of Arginyl-glycyl-Aspartic acid peptides to an adhesion receptor on platelets. J Biol Chem 263:3943-3951.
9. Farrell DH, Thiagarajan P, Chung DW and Davie EW (1992) Role of fibrinogen alpha and gamma chain sites in platelet aggregation. Proc Natl Acad Sci USA 89:19729-10732.
10. 3 integrin) confers fibrinogen- and activation-dependent aggregation on heterologous cells. Blood 78:369-376.
11. Gan Z, Gould RJ, Jacobs JW, Friedman PA and Polokoff MA (1988) Echistatin. A potent platelet aggregation inhibitor from the venom of the viper Echis Carinatus. J Biol Chem 263:19827-19832.
12. 2+-binding properties of the platelet glycoprotein IIb ligand-interacting domain. J Biol Chem 267:1001-1007.
13. Gurrath M, Muller G, Kessler H, Aumailley M and Timpl R (1992) Conformation/ activity studies of rationally designed potent anti-adhesive ROD peptides. Eur J Biochem 210:911-921.
14. Hartman GD, Egbertson MS, Halczenko W, Laswell WL, Duggan ME, Smith RL, Naylor AM, Manno PD, Lynch RJ, Zhang G, Chang CT-C and Gould RJ (1992) Non-peptide fibrinogen receptor antagonists 1. Discovery and design of exosite inhibitors. J Med Chem 35:4640-4642.
15. Honda S, Tomiyama Y, Pelletia AJ, Annis D, Honda Y, Orchekowski R, Ruggeri Z and Kunicki TJ (1995) Topology of ligand-induced binding states, including a novel cation-sensitive epitope (AP5) at the amino terminus of the human integrin beta3 subunit. J Biol Chem 270:11947-11952.
16. Kiewiarowski S, McLane MA, Kloczewiak M and Stewart GJ (1994) Disintegrins and other naturally occurring antagonists of platelet fibrinogen receptors. Semin Hematol 31:289-300.
17. Kloczewiak M, Timmons S and Hawiger J (1982) Localisation of a site interacting with human platelet receptor on carboxy-terminal segment of human fibrinogen. Biochem Biophys Res Commun 107:181-187.
18. Konus WC, Hadvary P, Haering P and Steiner B (1992) Conformational modulation of purified glycoprotein (GP) II-IIIa allows proteolytic generation of active fragments from either active or inactive GPII-IIIa. J Biol Chem 267:18844-18851.
19. Ku TW, Ali FE, Barton LS, Bean JW, Bondinell WE, Burgess JL, Callahan JF, Calvo RR, Chen L, Eggleston DS, Gleason JG, Huffman W, Hwang SM, Jakes DR, Karash CB, Keenan RM, Kopple KD, Miller WH, Newlander KA, Nichols A, Parker MF, Peishoff CE, Samanen JM, Uzinskas I and Venslavsky JW (1993) Direct design of a potent non-peptide fibrinogen receptor antagonist based on the structure and conformation of highly constrained cyclic RGD peptides. J Am Chem Soc 115:8861-8862.
20. Ku TW, Miller WH, Bondinell WE, Erhard EF, Keenan RM, Nichols AJ, Peishoff CE, Samanen JM, Wong AS and Huffman WF (1995) Potent nonpeptide fibrinogen receptor antagonists which present an alternative pharmacophore. J Med Chem 38:9-12.
21. Laemmli UK (1970) Cleavage of structural proteins during assembly of the head of the bacteriophage T4. Nature 227:680-685.
22. Lampugnani MG, Bernasconi S, Neri P, Lozzi L, Gavazzi I, Marchisiol PC and Dejena E (1991) Role of manganese in MG-63 osteosarcoma cell attachment to fibrinogen and von Willebrand factor. Lab Invest 65:96-103.
23. Landvatter SWJ (1993) Labeled Comp. Radiopharm 33:863.
24. Loftus JC, Halloran CE, Ginsberg MH, Feigen LP, Zablocki JA and Smith JW (1996) The amino-terminal one-third of alpha IIb defines the ligand recognition specificity of integrin alpha IIb beta 3. J Biol Chem 271:2033-2039.
25. Lundeen JE and Gordon JH (1986) Receptor Binding in Drug Research, Chapter 2 (O'Brien R, ed) Marcel Dekker, New York.
26. Marguerie GA, Plow EF and Edgington TS (1979) Human platelets possess an inducible and saturable receptor specific for fibrinogen. J Biol Chem 254:5357-5362.
27. Marguerie GA, Edgington TS and Plow EF (1980) Interaction of fibrinogen with its platelet receptor as part of a multistep reaction in ADP-induced platelet aggregation. J Biol Chem 255:154-161.
28. Munson PJ and Rodbard D (1980) LIGAND: A versatile computerized approach for characterisation of ligand-binding systems. Anal Biochem 107:220-239.
29. Parise LV and Phillips DR (1985) Reconstitution of the purified platelet fibrinogen receptor. J Biol Chem 260:10698-10707.
30. Parise LV, Helgerson SL, Steiner B, Nannizzi L and Phillips DR (1987) Synthetic peptides derived from fibrinogen and fibrinectin change the conformation of purified platelet glycoprotein IIb-IIIa. J Biol Chem 262:12597-12602.
31. Peishoff CE, Ali FE, Bean JW, Calvo R, D'Ambrosio CA, Eggleston DS, Hwang SM, Kline TP, Koster PF, Nichols A and Samanen J (1992) Investigation of conformational specificity at GPIIb/IIIa: Evaluation of conformationally constrained RGD peptides. J Med Chem 35:3962-3969.
32. Pierschbacher MD and Ruoslahti E (1987) Influence of stereochemistry of the sequence Arg-Gly-Asp-Xaa on binding specificity in cell adhesion. J Biol Chem 262:17294-17298.
33. Plow EF and Ginsberg MH (1988) Cellular adhesion: GPIIb/IIIa as a prototypic adhesion adhesion receptor. Prog Hemost Thromb 9:117-156.
34. Pytela R, Pierschbacher MD, Ginsberg MH, Plow EF and Ruoslahti E (1986) Platelet membrane glycoprotein IIb/IIIa: member of a family of arg-gly-asp-specific adhesion receptors. Science 231:1559-1562.
35. Samanen J, Ali F, Romoff T, Calvo R, Sorenson E, Vasko J, Storer B, Berry D, Bennett D, Strohsacker M and Nichols A (1991) Development of a small RGD peptide fibrinogen receptor antagonist with potent antiaggregatory activity in vitro. J Med Chem 34:3114-3125.
36. Samanen J, Ali FE, Barton L, Bondinell W, Burgess J, Callahan J, Calvo R, Chen L, Erhard K, Hwang S-M, Jakas D, Keenan R, Ku T, Kwon C, Lee C-P, Miller W, Kewlander K, Nichols A, Peishoff C, Rhodes G, Ross S, Simpson D, Takata D, Yellin TO, Uzsinskas I, Venslavsky J, Wong A, Yuan C-K and Huffman W (1995) GPIIb/IIIa antagonists with long oral duration designed from cyclic peptides. Proceedings 14th American Peptide Symposium, Mayflower Scientific, Kingswinford, England.
37. Samanen JM, Ali FE, Barton LS, Bondinell WE, Burgess JL, Callahan JF, Calvo RR, Chen W, Chen L, Erhard K, Feuerestin G, Heys R, Hwang S-M, Jakas DR, Keenan RM, Ku TW, Kwon C, Lee C-P, Miller WH, Newlander KA, Nichols A, Parker M, Peishoff CE, Rhodes G, Ross S, Shu A, Simpson R, Takata D, Yellin TO, Uzsinskas I, Venslavsky JW, Yuan C-K and Huffman WF (1996) Potent, selective, orally active 3-oxo-1,4-benzodiazepine GPIIb/IIIa integrin antagonists. J Med Chem 39:4867-4870.
38. Savage B, Marzec UM, Chao BH, Harker LA, Maraganore JM and Ruggeri ZM (1990) Binding of the snake venom-derived proteins applagin and echistatin to the arginine-glycine-aspartic acid recognition site(s) of platelet glycoprotein IIb/IIIa complex inhibits receptor function. J Biol Chem 265:11766-11772.
39. Scatchard G (1949) The attraction of proteins for small molecules and ions. Ann NY Acad Sci 51:660-672.
40. Shattil SJ, Hoxie JA, Cunnimgham M and Brass LF (1985) Changes in the platelet membrane glycoprotein IIb-IIIa complex during platelet activation. J Biol Chem 260:11107-11111.
41. 3-integrins. J Biol Chem 269:960-967.
42. 2+-dependent binding of a synthetic Arg-Gly-Asp (RGD) peptide to a single site on the purified platelet glycoprotein IIb-IIIa complex. J Biol Chem 264:13102-13108.
43. Suehiro K, Smith JW and Plow EF (1996) The ligand recognition specificity of beta3 integrins. J Biol Chem 271:10365-10371.
44. 3. FEBS Lett 358:179-181.
45. Topol EJ (1995) Novel antithrombotic approaches to coronary artery disease. Am J Cardiol 75:27B-33B.